Sparsha Pharma International Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 8.56 Cr
- Company Age 18 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.20 Cr
- Satisfied Charges ₹ 8.00 Cr
- Revenue Growth 47.43%
- Profit Growth 335.62%
- Ebitda 110.75%
- Net Worth 14.82%
- Total Assets 4.84%
About Sparsha Pharma International
Sparsha Pharma International Private Limited (SPIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 February 2007 and has a history of 18 years. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.56 Cr.
The company currently has active open charges totaling ₹1.20 Cr. The company has closed loans amounting to ₹8.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sparsha Pharma International Private Limited India is J Sainathan as COMPANY SECRETARY. Hiroyuki Kubo, Shosaku Murayama, Dange Veerapaneni, and Two other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TG2007PTC052719
- Company No.
052719
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2007
- Date of AGM
22 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sparsha Pharma International?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dange Veerapaneni  | Managing Director | 11-Apr-2008 | Current |
J Sainathan  | Company Secretary | 27-Jan-2015 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shosaku Murayama  | Director | 23-Nov-2008 | Current |
| Hiroyuki Kubo | Director | 26-Mar-2018 | Current |
| Bobba Venkatadri | Director | 11-Apr-2008 | Current |
| Hema Veerapaneni | Director | 07-Sep-2007 | Current |
Financial Performance of Sparsha Pharma International.
Sparsha Pharma International Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 47.43% increase. The company also saw a substantial improvement in profitability, with a 335.62% increase in profit. The company's net worth Soared by an impressive increase of 14.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sparsha Pharma International?
In 2021, Sparsha Pharma International had a promoter holding of 37.57% and a public holding of 62.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
A.P.I.D.C. Venture Capital Private LimitedBobba Venkatadri is a mutual person
- Jaya Diagnostic And Research Centre Ltd
Bobba Venkatadri is a mutual person
Charges (Loans)
₹1.20 Cr
₹8.00 Cr
Charges Breakdown by Lending Institutions
- : 1.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Sep 2013 | ₹1.20 Cr | Open | |
| 06 May 2013 | Technology Developement Board | ₹8.00 Cr | Satisfied |
How Many Employees Work at Sparsha Pharma International?
Sparsha Pharma International has a workforce of 77 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sparsha Pharma International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sparsha Pharma International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
